| Age (yr) | 0.003 |
| <60 | 21 (30.4) | 41 (55.4) | |
| ≥60 | 48 (69.6) | 33 (44.6) | |
| Sex | 0.077 |
| Male | 49 (71.0) | 42 (56.8) | |
| Female | 20 (29.0) | 32 (43.2) | |
| Tumor location | 0.442 |
| Antrum | 38 (55.1) | 36 (48.6) | |
| Corpus | 31 (44.9) | 38 (51.4) | |
| Early gastric cancer | 24 (34.8) | 34 (45.9) | 0.174 |
| Advanced gastric cancer | 45 (65.2) | 40 (54.1) | |
| WHO classification | 0.061 |
| Tubular adenocarcinoma | 51 (73.9) | 39 (52.7) | |
| Papillary adenocarcinoma | 0 (0.0) | 1 (1.4) | |
| Mucinous adenocarcinoma | 3 (4.3) | 6 (8.1) | |
| Signet ring cell carcinoma | 15 (21.7) | 28 (37.8) | |
| Lauren classification | 0.038 |
| Intestinal | 39 (56.5) | 29 (39.2) | |
| Diffuse & mixed | 30 (43.5) | 45 (60.8) | |
| Vascular invasion (n=140) | 0.497 |
| No | 50 (74.6) | 58 (79.5) | |
| Yes | 17 (25.4) | 15 (20.5) | |
| Lymphatic invasion | 0.01 |
| No | 31 (44.9) | 49 (66.2) | |
| Yes | 38 (55.1) | 25 (33.8) | |
| Perineural invasion (n=140) | 0.104 |
| No | 43 (64.2) | 56 (76.7) | |
| Yes | 24 (35.8) | 17 (23.3) | |
| T stage | 0.224 |
| Tis, T1 | 23 (33.3) | 32 (43.2) | |
| T2, T3, T4 | 46 (66.7) | 42 (56.8) | |
| N stage | 0.022 |
| N0 | 25 (36.2) | 41 (55.4) | |
| N1, N2, N3 | 44 (63.8) | 33 (44.6) | |
| M stage | 0.233 |
| M0 | 61 (88.4) | 70 (94.6) | |
| M1 | 8 (11.6) | 4 (5.4) | |
| CEA (n=130) | 0.787 |
| ≤5 | 60 (89.6) | 55 (87.3) | |
| >5 | 7 (10.4) | 8 (12.7) | |
| CA19-9 (n=124) | 0.81 |
| ≤27 | 56 (84.8) | 48 (82.8) | |
| >27 | 10 (15.2) | 10 (17.2) | |